PT UBC Medical Indonesia Tbk (IDX:LABS)
Indonesia
· Delayed Price · Currency is IDR 128.00
+5.00 (4.07%)
May 14, 2025, 9:49 AM WIB
IDX:LABS Revenue
In the year 2024, PT UBC Medical Indonesia Tbk had annual revenue of 147.64B IDR with 8.00% growth. PT UBC Medical Indonesia Tbk had revenue of 41.21B in the quarter ending December 31, 2024.
Revenue
147.64B
Revenue Growth
+8.00%
P/S Ratio
3.29
Revenue / Employee
2.38B
Employees
62
Market Cap
485.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 147.64B | 10.94B | 8.00% |
| Dec 31, 2023 | 136.70B | 43.41B | 46.53% |
| Dec 31, 2022 | 93.29B | -36.67B | -28.22% |
| Dec 31, 2021 | 129.96B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition